ESPI Current Reports

Current report no. ESPI 4/2026
Date of preparation: 22 January 2026

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Conclusion of a cooperation agreement with an American company for the supply of a new class of optical instruments for Earth observation and the commercialisation of satellite data in the Data-as-a-Service model.

Legal basis: Article 17(1) of the MAR Regulation, confidential information

The Management Board of Scanway S.A. (the “Company”, “Scanway”) hereby announces that on 22 January 2026 it entered into a cooperation agreement (the “Agreement”) with a US-based customer (“Partner”). The subject of the Agreement is the development and delivery of a new class of optical instruments for Earth observation, which will be used in the satellite constellation for Earth observation (“Project”) being built by the Partner. The concluded Agreement constitutes the first stage of preparatory work, preceding the operational launch of the Project by the Partner. The Company will report on further significant events related to the implementation of the Project in the relevant reports.

The estimated value of the Agreement may reach approximately USD 4,300,000 (equivalent to approximately PLN 15.5 million at the exchange rate of 22 January 2026) and relates to payment for the delivery of the first optical instrument. The remuneration due to the Company will be paid in instalments, upon acceptance of specific Project milestones. The planned delivery of the first instrument to the Partner will take place within 24 months of the Project’s operational launch.

The agreement covers the supply of optical instruments for Earth observation, as well as the possible commercialisation of data generated by the Company’s first optical instrument, which will be used in a satellite constellation built by the Partner. The commercialisation of data is to be carried out in the Data-as-a-Service (DaaS) model – in line with market practice, this model involves providing customers with satellite data streams on a subscription basis or under long-term contracts without them having to bear the costs of building and maintaining their own satellite infrastructure. This will enable the Company to generate recurring revenues from providing international external customers with access to the data stream generated by its optical instrument.

The financing of further optical instruments to be used in the Project is planned through co-financing with the Partner, based, among other things, on cash generated from the DaaS model and distributed between Scanway and the Partner according to an agreed mechanism for sharing profits from the sale of data from the first Earth observation satellite. The Company will be entitled to a percentage of the profit from the first commercialised data package.

With regard to provisions concerning possible contractual penalties, warranty clauses, product liability, etc., the Agreement does not deviate from market standards relating to these issues commonly applied in agreements of this type.

The telescope to be developed by Scanway as part of the Project will belong to a new class of instruments developed by the Company. In terms of design, the instrument will integrate several cameras operating in different wave ranges. In Scanway’s opinion, the instrument’s architecture and selected components will enable the Company to further expand its product range, enter new markets and develop cooperation with leading entities in the space sector in the United States.

The cooperation agreement with the Partner is another element, following the contract with the European Space Agency for the processing of satellite images of the Moon (as announced by the Company in current report ESPI No. 18/2025), of building the Company’s exposure to the downstream segment, the most profitable part of the space sector. Market practice and available, up-to-date industry studies (prepared, among others, by the European Space Agency and the analytical and consulting company BryceTech) indicate that regular processing and commercialisation of data can generate long-term revenues that exceed the value of the entire device (satellite).

The partner is a space sector entity based in the United States, specialising in satellite technologies, including the design and manufacture of components and complete satellites. It has a management and engineering team with many years of experience in the design and implementation of large space missions, in particular in the field of integration, testing and satellite operations for commercial customers and government institutions.

The agreement is directly in line with the “Scanway S.A. Strategy for 2026-2028”, in particular by strengthening and commercialising the Company’s expertise in building a complete optical data chain, including acquisition, processing, analytics and event prediction based on them (APAP). Additionally, in the Company’s opinion, the Agreement may have a significant impact on the development prospects and financial situation of Scanway in the coming years.

Current report no. ESPI 2/2026
Date of preparation: 6 January 2026

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Notification of a transaction by a closely related person received pursuant to Article 19 of MAR

Legal basis: Article 19(3) of the MAR Regulation, information on transactions carried out by persons discharging managerial responsibilities.

The Management Board of Scanway S.A. (the “Company”, “Scanway”) hereby announces that today the Company received from the President of the Management Board of Scanway and the family foundation controlled by him revised notifications related to a change in the total number of votes in the Company in connection with the foundation acquiring 100,000 series H shares and their registration by the District Court for Wrocław Fabryczna in Wrocław, 6th Commercial Division of the National Court Register.000 series H shares and their registration by the District Court for Wrocław Fabryczna in Wrocław, 6th Commercial Division of the National Court Register.

According to the notifications received, Mr Jędrzej Kowalewski, President of the Management Board of Scanway, currently holds, indirectly through a family foundation, 255,370 shares in the Company, entitling him to the same number of votes at the General Meeting, which represents 15.27% of the Company’s share capital and the same share in the total number of votes in the Company.

The content of the notifications received is provided by the Company in the appendix to this current report.

Current report no. ESPI 1/2026
Date of preparation: 6 January 2026

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Notification of a transaction by a closely related person received pursuant to Article 19 of MAR

Legal basis: Article 17(1) of the MAR Regulation, confidential information

The Management Board of Scanway S.A. (the “Company”, “Scanway”) hereby announces that today the Company received a notification prepared pursuant to Article 19 of MAR from a person closely related to the President of the Management Board of the Company (family foundation) in connection with the transaction referred to in current report ESPI No. 35/2025. The content of the notification received is provided by the Company in the attachment to this current report.

Current report no. ESPI 40/2025
Date of preparation: 19 December 2025

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Completion of the project and implementation of all activities under the contract with Ghalam LLP

Legal basis: Article 17(1) of the MAR Regulation, confidential information

The Management Board of Scanway S.A. (“Company”) hereby announces that today it has been confirmed that all work and activities covered by the contract (“Agreement”) with Ghalam LLP (“Ghalam”), concluded on 21 December 2023, about which the Company reported in its current report ESPI No. 3/2023, have been completed. The subject of the Agreement was the delivery by the Company of two telescope models – an optical system and an electronic subsystem for data acquisition from an optoelectronic sensor – capable of integration with a nanosatellite, as well as engineering support throughout the entire process of design, integration and testing of telescopes and nanosatellites.

Teleskopy wyprodukowane przez Spółkę i dostarczone do Ghalam obejmowały modele klasy inżynierskiej oraz modele lotne.

The contract has been completed and fully settled.

Current report no. ESPI 38/2025
Date of preparation: 16 December 2025

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Company receives information about the European Space Agency’s decision to secure funding for a second optical instrument for Intuitive Machines from the USA

Legal basis: Article 17(1) of the MAR Regulation, confidential information

The Management Board of Scanway S.A. (the “Company”, “Scanway”) announces that on 16 December 2025, it was informed of the decision of the European Space Agency (“ESA”) to secure funding with an estimated value of EUR 3.3 million for the preparation and delivery by the Company of a second optical instrument, which is planned to be placed in one of the next Intuitive Machines (“IM”) missions related to the exploration of the Moon.

Further detailed arrangements will be the subject of separate discussions between the Company, ESA and IM, which should be finalised following a positive evaluation of the Company’s bid, completion of the tender procedure and signing of the final contract with ESA. The Company will provide information on subsequent stages and decisions in this regard in separate announcements.

The information received by the Company today creates an opportunity for potential expansion of cooperation with Intuitive Machines, initiated by the first order for a lunar observation instrument on 20 December 2024, as announced by the Company in its current report ESPI No. 23/2024. The report indicated that cooperation with IM may be developed in the future by placing further optical instruments on satellites carrying out lunar missions.

Intuitive Machines is a leading American space company, listed on NASDAQ with a market capitalisation of over $2 billion (as of 15 December 2025). It is involved in space exploration and the construction of lunar infrastructure, cislunar communication systems and the development of navigation services for space missions. In February 2024, it made history as the first private organisation to land on the Moon.

Cooperation with IM is a key area of development included in the new “Scanway Development Strategy for 2026-2028”, concerning the development of the Deep Space segment, including lunar exploration. The company strives to cooperate with global leaders in the sector, such as Intuitive Machines. Potential deepening of cooperation with IM will allow the Company to strengthen its expertise in missions beyond Earth orbit and increase its exposure to the American market, the world’s largest space sector market.

The potential receipt of an order from ESA for a second optical instrument for Intuitive Machines may have a significant impact on the development prospects and financial situation of Scanway in the coming years.

Current report no. ESPI 37/2025
Date of preparation: 7 December 2025

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Activation of the camera in the telescope from the PIAST satellite constellation

Legal basis: Article 17(1) of the MAR Regulation, confidential information

The Management Board of Scanway S.A. (“Scanway”, “Company”) announces the successful launch of the Company’s electronic camera systems integrated with a telescope developed by the Space Research Centre of the Polish Academy of Sciences (“CBK PAN”) in the PIAST-M satellite of the PIAST constellation, launched into space on 28 November 2025.

The activation of the camera’s electronic systems confirms its readiness for further start-up and calibration work. At the same time, it has been confirmed that all key operating parameters, including nominal voltage and current values, as well as the temperature of the electronic systems, are within the specified limits.

The PIAST (Polish ImAging SaTellites) programme is being implemented by a consortium of Polish entities associated with the space sector, led by the Military University of Technology. Scanway S.A. is responsible for supplying two complete optical instruments (a telescope and a camera) for PIAST-S1 and PIAST-S2, as well as a camera for PIAST-M. The other consortium members are: Creotech Instruments S.A., Łukasiewicz Research Network – Institute of Aviation, PCO S.A. and CBK PAN.

The project is co-financed by the National Centre for Research and Development as part of the SZAFIR programme.

Current report no. ESPI 36/2025
Date of preparation: 1 December 2025

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Notifications of changes in the total number of votes in Scanway

Legal basis: Article 70(1) of the Act on Public Offering – acquisition or disposal of a significant block of shares

The Management Board of Scanway S.A. (the “Company”, “Scanway”) hereby announces that today the Company received notifications from the President of the Management Board of Scanway and the family foundation controlled by him regarding a change in the total number of votes in the Company in connection with the registration by the District Court for Wrocław Fabryczna in Wrocław, VI Commercial Division of the National Court Register, of an increase in the Company’s share capital from PLN 155,000.00 to PLN 157,281.00 through the issue of 22,810 series G shares with a nominal value of PLN 0.10 per share.

According to the notifications received, Mr Jędrzej Kowalewski, President of the Management Board of Scanway, currently holds, indirectly through a family foundation, 155,370 shares in the Company, entitling him to the same number of votes at the General Meeting, which represents 9.88% of the Company’s share capital and the same share in the total number of votes in the Company.

The content of the notifications received is provided by the Company in the appendix to this current report.

Current report no. ESPI 35/2025
Date of preparation: 26 November 2025

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Subscription and payment for new issue shares

Legal basis: Article 17(1) of the MAR Regulation, confidential information

With reference to ESPI current report No. 32/2025 on obtaining additional financing through the issue of new series H bearer shares, the Management Board of Scanway S.A. (“Company”) hereby announces that in connection with the agreement concluded between the Company and the shareholder – Jędrzej Kowalewski Family Foundation (“Shareholder”) for the acquisition of 100,000 series H bearer shares, on 26 November 2025, the Company received funds contributed by the Shareholder to cover the above-mentioned shares in the amount of PLN 15,300,000.

The funds obtained by the Company as a result of the issue will be allocated to the implementation of the Company’s development strategy referred to in current report No. 28/2025 of 30 September 2025.

Information on the registration of series H shares in the National Court Register will be disclosed to the public in a relevant current report.

Current report no. ESPI 33/2025
Date of preparation: 24 November 2025

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Notifications of changes in the total number of votes in Scanway

Legal basis: RN_POSITION_16_165

The Management Board of Scanway S.A. (the “Company”, “Scanway”) hereby announces that today the Company received a notification from a family foundation controlled by the President of the Management Board of Scanway regarding a change in the total number of votes in the Company in connection with the sale by the foundation of 100,000 shares in Scanway S.A., which entitle the holder to the same number of votes at the General Meeting and represent 6.45% of the share capital and the same share in the total number of votes in Scanway S.A.

The above sale of shares results from the implementation of an investment agreement concluded between the Company and the foundation and a selected institutional investor managing a group of qualified investors, about which the Company informed in its current report ESPI No. 32/2025.

Following the above transaction, the Jędrzej Kowalewski Family Foundation holds 155,370 shares in Scanway S.A., which entitles it to the same number of votes at the General Meeting and represents 10.02% of the share capital and the same share in the total number of votes in Scanway S.A.

Additionally, on the same day, the Company also received a notification regarding a change in the share of the total number of votes in the Company held by the above-mentioned institutional investor, i.e. investment funds managed by TFI PZU S.A.

The content of the notifications received is provided by the Company in the appendix to this current report.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current report no. ESPI 32/2025
Date of preparation: 21 November 2025

Abbreviated name of the issuer: SCANWAY S.A.

Subject: Adoption by the Company’s Management Board of a resolution on the intention to obtain additional financing and conclusion of an investment agreement in connection with the adopted resolution concerning the manner and procedure for acquiring new issue shares and selling the Company’s existing shares.

Legal basis: Article 17(1) of the MAR Regulation, confidential information

THIS CURRENT REPORT AND THE INFORMATION CONTAINED THEREIN ARE NOT INTENDED FOR DISCLOSURE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE TERRITORY OF THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA, JAPAN OR OTHER COUNTRIES WHERE SUCH DISTRIBUTION, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS CURRENT REPORT IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION. PLEASE READ THE IMPORTANT INFORMATION AT THE END OF THIS REPORT.

The Management Board of Scanway S.A. with its registered office in Wrocław (the “Issuer” or “Company”) hereby announces that today the Management Board of the Company adopted a resolution to commence the process of obtaining additional financing for the Company through the issue of new series H bearer shares with a nominal value of PLN 0.10 (the “New Issue Shares”). The financing will be carried out in cooperation with the Company’s shareholder, Jędrzej Kowalewski Family Foundation (“Family Foundation”, “Shareholder”).

In order to implement the above-mentioned resolution, today the Company concluded an investment agreement with the Shareholder and a selected institutional investor managing a group of qualified investors (collectively referred to as the “Investor”) concerning the sale by the Family Foundation to the Investor of the shares specified below and the acquisition by the Foundation of newly issued shares (the “Investment Agreement”). “Investor”) an investment agreement concerning the sale by the Family Foundation to the Investor of the shares indicated below and the acquisition by the Foundation of newly issued shares (“Investment Agreement”). The process is carried out in such a way as to enable the new investor to acquire existing shares of the Company, already introduced to organised trading in the Alternative Trading System on the NewConnect market (“ATS”). The detailed procedure for obtaining financing is described below.

As a result of concluding the Investment Agreement, on 21 November 2025, the Shareholder notified the Company of placing an order to sell 100,000 ordinary bearer shares of the Company with a nominal value of PLN 0.10 each, introduced to trading on the ASO (“Offer”) representing 6.45% of the Company’s share capital, entitling to 100,000 (6.45%) votes at the Company’s General Meeting (“Sold Shares”). The sale price of the Shares Sold was PLN 153 per Share Sold, i.e. a total of PLN 15,300,000. The offer and sale were made without the obligation to prepare or approve a prospectus or other offering document.

In further steps, the Company’s Management Board will adopt a resolution on increasing the share capital by issuing 100,000 New Issue Shares, based on the authorisation granted to the Management Board in the Company’s Articles of Association, i.e. within the limits of the target capital, and the Shareholder will acquire New Issue Shares in a number corresponding to the number of Sold Shares, i.e. 100,000 shares. The unit issue price of the New Issue Shares will be equal to the sale price of the Sold Shares and will amount to PLN 153.

1) The funds obtained by the Shareholder from the sale of the Sold Shares in the full amount of PLN 15,300,000 will be allocated by the Shareholder to pay the subscription price for the New Issue Shares. The agreement for the acquisition of New Issue Shares will be concluded within 5 business days from the date of settlement of the block trade concerning the Shares for Sale, and the price for the acquisition of New Issue Shares will be paid no later than on the next business day.
2) In order to enable the Transaction to be carried out, the Shareholder and the Company have concluded an agreement with Dom Maklerski Navigator S.A., in which the latter has agreed to the sale of the Shares being sold, while at the same time undertaking a lock-up obligationon all New Issue Shares to be acquired by the Shareholder, effective from the date of their registration in the Shareholder’s securities account. The lock-up period for all shares held by the Shareholder will expire on 31 December 2025.

Pursuant to the Investment Agreement:
1) The Company’s Management Board undertook to adopt a resolution on increasing the share capital, excluding the pre-emptive rights of existing shareholders, in full by issuing New Issue Shares, which will be offered exclusively to the Shareholder at a unit issue price equal to the sale price of the Shares for Sale, i.e. PLN 153 (“Issue Resolution”); 2) The Shareholder undertook to subscribe for New Issue Shares; 3) The Shareholder undertook to pay the entire sale price of the Shares for Sale as a cash contribution to pay for the subscription price of the New Issue Shares.

The funds obtained by the Company as a result of the New Issue will be allocated to the implementation of the Company’s development strategy referred to in Current Report No. 28/2025 of 30 September 2025.

[IMPORTANT INFORMATION

This report does not constitute an offer to sell the Issuer’s securities in the United States of America, Canada, Japan, Australia or any other jurisdiction where such an offer would constitute a violation of applicable law or require registration, notification or authorisation. The Company’s Securities have not been and will not be registered under the provisions of the US Securities Act and may not be offered or sold in the United States of America. The Issuer’s securities and this report have not been and will not be registered, approved or notified in any country outside the Republic of Poland, in particular in accordance with Regulation (EU) 2017/1129 of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, and the provisions of law issued on its basis, and may not be offered outside the Republic of Poland (including in other European Union countries), unless such an offer could be made in a given country in accordance with the law without the need for the Shareholder, the Issuer and their advisors to meet any additional legal requirements. Any investor residing or having its registered office outside the Republic of Poland should familiarise themselves with the relevant provisions of Polish law and the regulations of other countries that may apply to them. This report does not contain or constitute an offer to sell securities or an invitation to submit an offer to purchase securities or a recommendation to purchase securities. The report does not constitute a basis for making a decision to purchase the Company’s securities. Investing in the Issuer’s shares involves a high risk inherent in equity capital market instruments and risks related to the Issuer’s operations and the environment in which the Issuer operates. Before making an investment decision, investors should carefully review the available information about the Issuer and, if necessary, seek the advice of advisors, including legal advisors.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current Report No. ESPI 30/2025
Drafting date: 2025-10-30
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Completion of flight testing of the Earth observation instrument under the NarSha project with Nara Space Technology

Legal basis: Article 17 (1) of the MAR Regulation confidential information

With reference to ESPI Current Report No. 2/2025 regarding the conclusion of an agreement (the “Agreement”) with Nara Space Technology (“Nara Space”) for flight testing of the first Earth observation instrument under the NarSha project, the Board of Directors of Scanway S.A. (the “Company”, “Scanway”) announces the successful completion of the entire testing process and Nara Space’s acceptance of all data collected by the Company as of October 30, 2025. Thus, the Company has completed the processing phase (data processing phase), which brings it closer to starting work on the first flight model of the instrument. The successful outcome of the testing and completion of the data processing phase triggers the payment of the final tranche under the testing campaign in the amount of approximately $85.5 thousand out of the total amount of $285.1 thousand, and an additional $141.5 thousand in connection with the achievement of the milestone of the contract for the second flight model between Nara Space and Scanway, as the Company announced in ESPI Current Report No. 22/2024.

Completed flight tests confirmed the functionality and performance of the Scanway instrument under conditions of imaging real methane emissions from an altitude of about 2,000 to more than 3,000 meters above sea level. The engineering model of the Scanway instrument made it possible to observe the Earth’s surface and record a point source of methane emissions.

The tests resulted in six hyperspectral data sets – reprocessed images that confirm the functionality of the sensors, optics and processing in the Scanway instrument’s engineering model. The data set and test documentation were submitted to Nara Space and received approval.

The tests carried out are a key milestone in the development of the first observation instrument within the NarSha project, a constellation of microsatellites being built by Nara Space. Ultimately, the constellation will include at least 12 microsatellites and will become Korea’s first satellite system dedicated to global monitoring of point sources of methane emissions in near real time, with spatial resolution at the local level. The project is being carried out by a consortium of Nara Space Technology (leader), Scanway (observatory instrument provider), the Climate Technology Center of Seoul National University and the Korea Astronomy and Space Science Institute.

As part of the project, the Company is developing optical instruments for the first two microsatellites, scheduled for launch in late 2026. The project shows potential for further expansions with additional instruments for the constellation.

Nara Space’s acceptance of the documentation confirms Scanway’s competence in optical instruments and the timely implementation of the NarSha project schedule.

Participation in constellation projects is a strategic area of Scanway’s development and will continue within the framework of the “Scanway S.A. Development Strategy 2026-2028.” This area is key to building a repeatable order book by providing instruments for constellation-forming satellites and, in the future, for potential satellites that will replace existing constellations.

Jędrzej Kowalewski – President of the Management Board
Michał Zięba – Member of the Management Board

Current report no. ESPI 29/2025
Date of preparation: 21 October 2025
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Signing of the implementation agreement for the CAMILA project

Legal basis: Article 17(1) of the MAR Regulation – confidential information

With reference to current reports ESPI No. 4/2025, 4/2025K and 23/2025 concerning the implementation of the Country Awareness Mission in Land Analysis (“CAMILA”) project, the Management Board of Scanway S.A. (“Company”, “Scanway”) hereby announces that on 21 October 2025 it was notified of the mutual signing of an implementation agreement (“Agreement”) with Creotech Instruments S.A. (“Creotech”), which specifies the terms of cooperation within the CAMILA project.

The total value of the Agreement is approximately EUR 3.55 million, which includes funds previously released under the Authorisation to Proceed, as announced by the Issuer in its current report ESPI No. 23/2025.

Under the Agreement, Scanway will supply Creotech Instruments S.A., the general contractor for the CAMILA project, with two optical telescopes for Earth observation, namely:

– high-resolution (HR) telescope designed for a high-resolution optical satellite,

– low-resolution (LR) telescope designed for a lower-resolution optical satellite.

The implementation of the first phase of the Agreement, valued at approximately EUR 1 million, will last until the Preliminary Design Review (PDR) planned for the turn of the first and second quarters of 2026, covering, among other things, the Payload Feasibility Key Point. After this stage, Creotech Instruments S.A. and the European Space Agency (ESA) will decide whether to proceed to the next phase of the project. This transition is contingent upon a positive assessment of the results of the first phase.

The agreement also provides for the possibility of extension (“Options”) to include the delivery of an additional high-resolution optical telescope and support in operating the satellites after the constellation is launched, which is valued at an additional amount of up to approximately EUR 0.85 million.

The CAMILA project is financed from Poland’s contribution to the ESA under a bilateral agreement between the Ministry of Development and Technology and the European Space Agency.

The company will provide information on further significant steps in the implementation of the CAMILA project in subsequent current reports.

The implementation of the CAMILA project is part of one of the Company’s strategic development directions concerning the offering of its solutions for large public projects and is a direct result of the experience gained in the STAR VIBE, EagleEye, PIAST projects and, above all, commercial orders carried out by Scanway for customers from all over the world.

Jedrzej Kowalewski – President of the Management Board
Michał Zięba – Board Member

Current report no. ESPI 28/2025
Drafting date: 2025-09-30
Abbreviated name of the issuer: SCANWAY S.A.

Subject: adoption by the Board of Directors of Scanway S.A. “Development strategy of Scanway S.A. for 2026-2028”.

Legal basis: Article 17 (1) of the MAR Regulation – confidential information

The Board of Directors of Scanway S.A. (the “Company”) announces the adoption of the following on September 30, 2025. “Development Strategy of Scanway S.A. for 2026-2028” (the “Strategy”). The Strategy – presenting the most important assumptions of the Company’s development – is attached to this report.

The strategic goal for Scanway S.A. is to become one of the largest integrators of optical cargo in Europe by the end of 2028.

At the same time, the strategy objective formulated in this way paves the way for the Company’s long-term aspiration of becoming one of the world’s largest commercial optical payload integrators.

In the Strategy adopted today, the Board of Directors formulates the following operational goals for 2026-2028:
– Significantly scale up operations and technology activities in the main areas: Space _ Defense and Industry;

– The presence of the Company’s products in constellations of global leaders;

– roduction of a dozen optical cargoes per year in the price range of 0.5-2.0 million euros per unit as a result of participation in constellation projects;

– Presence in a portfolio of products that represent a complete, end-to-end optical data processing chain, from acquisition to processing, analytics to prediction.

Scanway S.A. intends to strengthen its position as an integrated European supplier of optical technologies for the space and industrial sectors, in which it will be supported by the realization of four, technological directions of development, which are further described in the strategy document:

– The first direction will be the development of optical instruments with very high resolution;

– The second direction is the development of data processing products;

– The third direction is cameras dedicated to the defense market and applications in the area of in-space servicing;

– The fourth direction involves strengthening our own supply chain.

At the same time, the Company will continue its existing business directions, which include constellation projects and the construction of increasingly large optical instruments, involvement in the defense sector, development in the area of deep space and lunar exploration, participation in large public programs, and development in the industrial sector involving image analysis.

In the coming quarters, the Company will focus on methodical scaling of operations, increasing production capacity and improving technological competence

and operational. The Strategy will be implemented on the basis of a stable financial foundation and responsible liquidity management. The Management Board is currently analyzing a broad spectrum of financing options for development plans. In the coming quarters, the Company will refine the target optimal structure for raising development capital.

The news of the adoption of the new Strategy was considered important for the Company, as it defines the directions of Scanway S.A.’s strategic development in the next few years to significantly increase the Company’s scale, competitiveness and stability. At the same time, the Strategy provides a reference point for further organizational development, investment decisions and cooperation with investors, institutional customers and strategic partners, among others.

in the context of the planned debut on the Main Market of the Warsaw Stock Exchange and participation in public programs.

Jedrzej Kowalewski – President of the Management Board
Michał Zięba – Board Member

Current report no. ESPI 27/2025
Drafting date: 2025-09-19
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Notification of change in the share of total votes in Scanway

Legal basis: Article 70(1) of the Act on Public Offering – acquisition or disposal of a significant block of shares

The Management Board of Scanway S.A. (“Company”, “Scanway”) announces that today the Company has received a notification from a family foundation controlled by Jędrzej Kowalewski, related to a change in its share in the total number of votes in the Company in connection with the registration by the District Court for Wrocław Fabryczna in Wrocław, VI Economic Department of the National Court Register of an increase in the Company’s share capital from PLN 139,500.00 to PLN 155,000.00 by issuing 155,000 series F shares with a nominal value of PLN 0.10 per share.

According to the notification received, the family foundation currently controlled by Jędrzej Kowalewski holds 255,370 shares, representing 16.48% of the Company’s share capital and the same percentage of the total number of votes in the Company.

The content of the notification received is provided by the Company in the attachment to this current report.

Jedrzej Kowalewski – President of the Management Board
Mikolaj Podgorski – Board Member

Current report no. ESPI 22/2025
Date of preparation: 19 August 2025
Abbreviated name of the issuer: SCANWAY S.A.

Subject: List of Shareholders Holding at Least 5% of the Number of Votes at the Extraordinary General Meeting of SCANWAY S.A.

Legal basis: Article 70(3) of the Act on Public Offering – General Meeting of Shareholders, list above 5%

The Management Board of Scanway S.A. with its registered office in Wrocław [the “Company”] hereby announces that at the Extraordinary General Meeting of the Company held on 18 August 2025 [the “EGM”], the shareholders holding more than 5% of the votes at the EGM were:

– PGE Ventures Sp. z o.o., which held 185,000 shares in the Company at the Extraordinary General Meeting, entitling it to 185,000 votes, which constituted 32.31% of the votes at that Extraordinary General Meeting and corresponded to 13.26% of the total number of votes in the Company.

– Lowercap Sp. z o.o. DFR ASI S.K.A., which held 42,700 shares in the Company at the Extraordinary General Meeting, entitling it to 42,700 votes, which constituted 7.46% of the votes at that Extraordinary General Meeting and corresponded to 3.06% of the total number of votes in the Company.

– Agencja Rozwoju Społecznego “ARS” Sp. z o.o., which held 48,400 shares in the Company at the Extraordinary General Meeting, entitling it to 48,400 votes, which constituted 8.45% of the votes at that Extraordinary General Meeting and corresponded to 3.47% of the total number of votes in the Company.

– Jędrzej Kowalewski Family Foundation, which held 100,370 shares in the Company at the Extraordinary General Meeting, entitling it to 100,370 votes, which constituted 17.53% of the votes at that Extraordinary General Meeting and corresponded to 7.19% of the total number of votes in the Company.

– The Government of Norway, which held 40,000 shares in the Company at the Extraordinary General Meeting, entitling it to 40,000 votes, which constituted 6.99% of the votes at that Extraordinary General Meeting and corresponded to 2.87% of the total number of votes in the Company.

– FAMILIAR S.A., SICAV-SIF, which held 30,000 shares in the Company at the Extraordinary General Meeting, entitling it to 30,000 votes, which constituted 5.24% of the votes at that Extraordinary General Meeting and corresponded to 2.15% of the total number of votes in the Company.

Jedrzej Kowalewski – President of the Management Board
Mikolaj Podgorski – Board Member

Current Report No. ESPI 21/2025
Drafting date: 2025-08-12
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Contract with Space Inventor to provide telescope for Danish Stars and ExoPlanets mission

Article 17(1) MAR – confidential information.

The Board of Directors of Scanway S.A. (the “Company”, “Scanway”) announces the signing of a contract (the “Agreement”) with Space Inventor (“SI”), based in Denmark, on 12/08/2025. The subject of the Agreement will be the delivery of a model of a flyby telescope for stellar astroseismography, which will be integrated into Space Inventor’s satellite platform and sent into Earth orbit as part of the “Stars and ExoPlanets” (“STEP”) scientific mission.

The value of the Agreement is €500,000 and covers a period of 12 months. The Company’s expected receipt of funds from the execution of the Agreement based on the agreed schedule will be 50% in 2025 and 50% in 2026. In terms of the provisions regarding possible contractual penalties, warranty provisions, product liability, etc. The Agreement does not deviate from commonly used market standards relating to these issues.

The STEP mission is scientific in nature and is being carried out by a consortium of Danish universities. The satellite platform for the mission will be provided by SI, with which Scanway signed a cooperation agreement in August 2024 (ESPI Current Report No. 8/2024) and with which it is implementing the Mani project (ESPI Current Report No. 24/2024).

The flight model of the telescope prepared and supplied by the Company will enable Danish scientists to make advanced astroseismographic observations. These observations will study the internal structure of stars by analyzing natural oscillations and pulsations, which will allow a better understanding of the evolutionary processes of stars and the physical phenomena occurring inside them. Astroseismography plays a key role in space research because it provides information about the structure and life cycle of stars.

The agreement between Scanway and SI will further strengthen the relationship and jointly offer products in global markets. At the same time, it opens up opportunities for the Company to build new relationships and partnerships to participate in advanced exploration projects, which is one of Scanway’s business directions.

SI to a Danish company that specializes in providing customers with microsatellite solutions weighing up to 200 kg. The innovative satellite platform developed by the company offers flexibility, modularity and is usable for different types of missions and in different orbits. Space Inventor also supplies a range of different components for satellites, such as reaction wheels and solar sensors.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current report no. ESPI 20/2025
Date of preparation: 29 July 2025
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Extension of the agenda of the Extraordinary General Meeting of Scanway S.A. convened for 18 August 2025 at the request of a Shareholder

The Management Board of Scanway Spółka Akcyjna with its registered office in Wrocław (the “Company” or the “Issuer”) hereby announces that, in connection with a motion received yesterday from an authorised Shareholder (Jędrzej Kowalewski Family Foundation) to extend the agenda of the Extraordinary General Meeting of Scanway S.A. convened for 18 August 2025 (“EGM”) and to include the following items:

1. Adoption of a resolution on the adoption of the Remuneration Policy for Members of the Management Board and Supervisory Board of Scanway S.A.;
2. Adoption of a resolution on the appointment of a Member of the Supervisory Board.

The Company hereby submits the amended proposed agenda for the Extraordinary General Meeting, taking into account the above-mentioned Shareholder’s motion.

The amendments to the agenda of the Extraordinary General Meeting consist in adding, after item 6, items 7 and 8 in the wording proposed by the Shareholder, and the existing item 7 (closure of the Meeting) has been marked as item 9.

1. Opening of the Assembly,
2. election of the Chair of the Meeting,
3. confirmation that the General Meeting has been duly convened and is capable of adopting resolutions,
4. adopting a resolution on the election of the Ballot Counting Committee or waiving its election,
5. adoption of the agenda,
6. adopting a resolution on increasing the Company’s share capital, depriving existing shareholders of their pre-emptive rights in full, dematerialising shares within the meaning of the Act on Trading in Financial Instruments, introducing newly issued shares to trading in an alternative trading system or admitting and introducing them to trading on a regulated market, and amending the Company’s Articles of Association,
7. adopting a resolution on the adoption of the Remuneration Policy for Members of the Management Board and Supervisory Board of Scanway S.A.;
8. adopting a resolution on the appointment of a Member of the Supervisory Board.
9. closing of the Assembly.

Attached, the Company submits draft resolutions for the Extraordinary General Meeting, which also include draft resolutions submitted by the Shareholder to the above-mentioned new items on the agenda of the Extraordinary General Meeting.

Mikołaj Podgórski – Member of the Management Board
Michał Zięba – Member of the Management Board

Current report no. ESPI 19/2025
Date of preparation: 3 July 2025
Abbreviated name of the issuer: SCANWAY S.A.

Temat: Zawiadomienie o zmianie udziału w ogólnej liczbie głosów w Scanway

Article 70(1) of the Act on Public Offering – acquisition or disposal of a significant block of shares

The Management Board of Scanway S.A. (the “Company”, “Scanway”) hereby announces that today the Company received a notification from a family foundation controlled by the President of the Management Board of Scanway regarding a change in the total number of votes in the Company in connection with the sale by the foundation, as part of an accelerated book-building process (“ABB”) in a block transaction of 176,500 shares in Scanway S.A., which entitle the holder to the same number of votes at the General Meeting and represent 12.65% of the share capital and the same share in the total number of votes in Scanway S.A. Following the above transaction, the “Jędrzej Kowalewski Family Foundation” holds 100,370 shares in Scanway S.A., which entitles it to the same number of votes at the General Meeting and represents 7.19% of the share capital and the same share in the total number of votes in Scanway S.A.

The content of the notification received is provided by the Company in the attachment to this current report.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current Report No. ESPI 18/2025
Drafting date: 2025-07-03
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Signing a contract with the European Space Agency to process satellite images of the Moon in a planned mission with Intuitive Machines of the US

Current Report No. ESPI 16/2025
Drafting date: 2025-06-30
Abbreviated name of the issuer: SCANWAY S.A.

Subject: List of shareholders holding at least 5% of the number of votes at the Annual General Meeting of SCANWAY S.A.

Art. 70 item 3 of the Public Offering Act – AGM list above 5%

The Board of Directors of Scanway S.A., based in Wrocław [“the Company”] informs that at the Annual General Meeting of the Company held on June 30, 2025 [“AGM”], the shareholders holding more than 5% of votes at this AGM were:

• Mr. Mikolaj Podgorski, who held 15,167 shares in the Company at the AGM, which entitled him to 15,167 votes, representing 8.50% of the number of votes at that AGM and corresponding to 1.09% of the total number of votes in the Company
• Mr. Przemysław Lutkiewicz, who held 11,500 shares in the Company at the AGM, which entitled him to 11,500 votes, representing 6.44% of the number of votes at that AGM and corresponding to 0.82% of the total number of votes in the Company
• Mr. Michal Zięba, who held 15,169 shares in the Company at the AGM, which entitled him to 15,169 votes, representing 8.50% of the number of votes at that AGM and corresponding to 1.09% of the total number of votes in the Company
• Government of Norway, which held 30,000 shares in the Company at the AGM, which carried 30,000 votes, representing 16.81% of the number of votes at that AGM and corresponding to 2.15% of the total number of votes in the Company
• Jędrzej Kowalewski Family Foundation, which held 100,000 shares in the Company at the AGM, which carried 100,000 votes, representing 56.04% of the number of votes at that AGM and corresponding to 7.17% of the total number of votes in the Company

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current Report No. ESPI 14/2025
Drafting date: 2025-06-24
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Convening of Extraordinary General Meeting for August 18, 2025

Article 17(1) MAR – confidential information.

Legal basis: § 4(2)(1) and (3) of Appendix No. 3 to the ATS Regulations “Current and periodic information provided in the Alternative Trading System on the NewConnect market”.

The Board of Directors of Scanway Spółka Akcyjna seated in Wrocław (the “Company” or the “Issuer”) announces that an Extraordinary General Meeting of Shareholders has been convened for August 18, 2025, which will commence at 11:00 am in the Notary’s Office of KBSR Kamiński i Partnerzy Notariusze Spółka Partnerska at the following address: ul. Ruska 3/4, 50-079 Wrocław.

The detailed agenda of the convened Extraordinary General Meeting of Shareholders of the Company includes:

The agenda for the Extraordinary General Meeting is as follows:

1. opening of the Assembly,
2. Election of the Chairman of the Assembly,
3. To ascertain the correctness of the convening of the General Meeting and its ability to adopt resolutions,
4. Adoption of a resolution on the election of the Ballot-Counting Committee or waiving its election,
5. Adoption of the agenda,
6. Adoption of a resolution on increasing the Company’s share capital depriving existing shareholders of their pre-emptive rights in full, dematerialization of shares within the meaning of the Act on Trading in Financial Instruments, introduction of new issue shares to trading in an alternative trading system or their admission and introduction to trading on a regulated market, and amendments to the Company’s Articles of Association,
7. closing of the Assembly.

The full text of the notice convening the Company’s Extraordinary General Meeting of Shareholders and the contents of the draft resolutions to be adopted at the Issuer’s Extraordinary General Meeting of Shareholders are included in the appendices to the report.

In addition, in accordance with Article 402 § 3 of the Commercial Companies Code, the full text of the notice convening the Extraordinary General Meeting, along with attachments, including forms for exercising the right to vote by proxy, was posted on the website https://investors.scanway.pl/.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current Report No. ESPI 13/2025
Drafting date: 2025-06-23
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Adoption by the Company’s Board of Directors of a resolution on the intention to raise additional financing, conclusion of an investment agreement on the manner and mode of subscription for new issue shares, and commencement of the accelerated book-building process

MAR Article 17.1 – confidential information.

THIS CURRENT REPORT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR DISTRIBUTION, PUBLICATION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN ANY PART, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION, PUBLICATION OR DISSEMINATION WOULD BE UNLAWFUL. THIS CURRENT REPORT IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION. PLEASE READ THE IMPORTANT INFORMATION AT THE END OF THIS REPORT.

The Board of Directors of Scanway S.A., based in Wrocław (the “Issuer” or the “Company”) announces that today the Company’s Board of Directors adopted a resolution to commence the process of raising additional financing for the Company through the issuance of new series F bearer shares with a nominal value of PLN 0.10 (the “New Issue Shares”). The transaction will be carried out in cooperation with the Company’s shareholder, Jędrzej Kowalewski Family Foundation (“Family Foundation”, “Shareholder”), which notified the Company of the commencement of the sale of the Company’s shares under an accelerated book-building process.

The process will be carried out in such a way as to enable investors to acquire existing shares of the Company already listed on the Alternative Trading System of the NewConnect market (“ATS”) for organized trading, according to the scheme indicated below (the “Transaction”):

1. The Shareholder will offer for sale by way of public offering only to qualified investors or less than 150 natural or legal persons other than qualified investors, without the obligation to prepare or approve a prospectus or other offering document, 155,000 ordinary bearer shares of the Company with a par value of PLN 0.10 each, listed on the ATS (the “Offering”) representing 11.11% of the Company’s share capital, entitling to 155,000 (11.11%) votes at the Company’s General Meeting (the “Sold Shares”);
2. The offering will be carried out through an accelerated book-building process conducted through Navigator Brokerage S.A. (“Navigator”, “Investment Firm”) (“ABB”);
3. In the event that, after consultation with the Investment Firm, the Shareholder deems the Investors’ demand for the Sale Shares to be adequate, the Shareholder may increase the number of Sale Shares included in the Offering to no more than 176,500;
4. The final number of Sale Shares will be determined and announced immediately after the completion of the accelerated book building process;
5. The Shareholder will take up New Issue Shares, in the number corresponding to the number of Sale Shares, but not exceeding 155,000.
6. The unit sale price of the Sale Shares will in each case be equal to the unit issue price of the New Issue Shares;
7. The funds received by the Shareholder from the sale of the Sale Shares in the amount equal to the product of the unit sale price of the Sale Shares and the number of New Issue Shares determined in accordance with Section 5) above shall be used by the Shareholder to pay the subscription price for the New Issue Shares, and such funds shall be deposited into the Company’s bank account within 5 business days after they are received by the Shareholder as an advance payment on the subscription price for the New Issue Shares;
8. The remaining funds received by the Shareholder from the sale of the Sale Shares (provided that the number of Sale Shares exceeds 155,000) will constitute its own funds and will not be used to acquire New Issue Shares.

The Shareholder further informed the Company that the ABB process will begin on June 24, 2025. It is expected to be completed on June 25, 2025, and the sale of the Sale Shares will be settled by June 27, 2025.

The funds raised by the Company through the issuance of New Issue Shares will be used to develop production capacity for current contracts, particularly in the area of telescopes with optical diameters larger than 200 mm, through the expansion of: (i) existing AIT (Assembly, Integration and Testing) infrastructure, and (ii) personnel in the Space segment. The estimated distribution of funds raised through the issuance of New Shares for each purpose (as % of gross proceeds from the issuance of New Shares) is presented below:

• 25% – expansion of engineering and operations staff, which should help increase the pace of project implementation and make development processes independent of competence bottlenecks,
• 55% – state-of-the-art AIT apparatus and manufacturing equipment, which should enable the realization of more complex and precise optical systems, in accordance with the requirements of customers in the space sector,
• 20% – to supply working capital. The Company intends to use part of the proceeds from the issuance of New Shares to secure funds for: (i) support the Company’s operational flexibility related to the growing scale of its business, and (ii) ensure the continued performance of contracts.

In order to make the Transaction possible:

1. The Company entered into an investment agreement with the Shareholder for the subscription of New Issue Shares (the “Investment Agreement”);
2. The Shareholder and the Company entered into an agreement with the Investment Firm, in which the Investment Firm agreed to sell the Sale Shares, with a lock-up commitment for all New Issue Shares to be subscribed for by the Shareholder, effective from their recording in the Shareholder’s securities account. The lock-up period for all shares held by the Shareholder will expire on December 31, 2025.

According to the Investment Agreement:

1. The Company undertook to convene an Extraordinary General Meeting for the purpose of adopting the necessary resolutions to increase the share capital excluding the pre-emptive rights of existing shareholders in full through the issuance of New Issue Shares in a number determined as described above, depending on the results of ABB, the subscription of which will be offered exclusively to the Shareholder at a unit issue price equal to the selling price of the Sale Shares (the “Issue Resolution”);
2. The Shareholder agreed to sell the Sale Shares under ABB;
3. The Shareholder undertook to subscribe for New Issue Shares in the number as determined as described above, depending on ABB’s performance, and at a unit issue price equal to the unit sale price of the Sale Shares;
4. The Shareholder agreed to pay the entire amount of the New Issue Shares allocated for acquisition to the Company as an advance payment on the price of their acquisition, each time within 5 business days from the crediting of his account with the amount of the sale price of a given block of Sale Shares;
5. With respect to the obligation to offer New Issue Shares to the Shareholder and their subscription by the Shareholder, the Investment Agreement constitutes a preliminary agreement within the meaning of the Civil Code Act of April 23, 1964, obligating its parties to conclude an agreement for the subscription of New Issue Shares, subject to the adoption of an Issue Resolution by the Extraordinary Shareholders’ Meeting;
6. The shareholder undertook to vote in favor of the Issuance Resolution;

The Shareholder reserved the right to change the terms and conditions of the sale of the Sale Shares, in particular to change the date of its execution and the number of Sale Shares and the number of New Issue Shares offered for subscription, as well as to cancel or terminate the offer to sell the Sale Shares, without giving any reason.

The Issuer will announce the convening of the Company’s Extraordinary General Meeting in separate current reports.

[IMPORTANT INFORMATION

This report does not constitute an offer for sale of the Issuer’s securities in the United States, Canada, Japan, Australia or any other jurisdiction where it would constitute a violation of applicable law or require registration, filing or authorization. The Company’s Securities have not been and will not be registered under the provisions of the U.S. Securities Act and may not be offered or sold in the United States of America. Neither the Issuer’s Securities nor this report have been and will be subject to registration, approval or notification in any country outside the Republic of Poland, in particular in accordance with Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017. on the prospectus to be published in connection with a public offering of securities or their admission to trading on a regulated market and the repeal of Directive 2003/71/EC and the laws issued pursuant thereto, and may not be offered outside the Republic of Poland (including other European Union countries), unless in the country in question such an offering could be lawfully made without the Shareholder, the Issuer and their advisors having to meet any additional legal requirements. Any investor residing or having its registered office outside the Republic of Poland should familiarize itself with the relevant provisions of Polish law and the regulations of other countries that may apply to it. This report does not contain or constitute an offer to sell securities or an invitation to make an offer to purchase securities or a recommendation to purchase securities. The report does not constitute a basis for making a decision to purchase the Company’s securities. Investing in the Issuer’s shares involves a high degree of risk inherent in equity capital market instruments and risks associated with the Issuer’s business and the environment in which the Issuer operates. Before making an investment decision, an investor should carefully review the available information on the Issuer and, if necessary, consult with advisors, including legal counsel].

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current Report No. ESPI 10/2025
Drafting date: 2025-06-13
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Agreeing with the European Space Agency on the terms of a contract for processing satellite images of the Moon in a planned mission with Intuitive Machines of the US

Legal basis: Article 17(1) MAR – confidential information.

The Board of Directors of Scanway S.A. (the “Company”, “Scanway”) announces that on June 13, 2025, key terms of a contract (the “Agreement”) were agreed with the European Space Agency (“ESA”). The subject of the planned Agreement will be the construction of a European multispectral data processing chain from Scanway’s optical instrument, which will be placed in lunar orbit in 2026 as part of the cooperation with Intuitive Machines (“IM”), described in ESPI Current Report No. 23/2024. Under the Agreement, the Company will develop a system for processing satellite data related to future lunar surface exploration. The Company has been recognized by the ESA as a competent and experienced entity entrusted with the work of processing images of the lunar surface.

The value of the Agreement between Scanway and ESA will be €500,000. The Company’s expected receipt of funds from the implementation of the Agreement based on the agreed schedule will be about 70% in 2025, about 10% in 2026 and about 20% in 2027. Implementation of the Agreement will last until 2027 (i.e., approximately one year after the launch of the IM satellite on which the Company’s product will be placed), and will primarily involve the processing of images of the lunar surface from specific targets, defined jointly by ESA, IM and Scanway, to a level that will enable the images to be stored in ESA databases, used for, among other things, research and scientific purposes, as well as for future exploration missions. As part of their discussions and agreements, the Company and IM have pre-defined specific targets for imaging the Moon.

Elements of the Company’s proprietary Hydra technology under development, i.e. advanced processing methods and high-performance data analysis, will be used to implement the scope of the Agreement. The synergy of solutions and competencies from the two industries in which the Company operates, i.e. complete systems for quality control in the Industry area and hardware solutions in the Space area, is a significant competitive advantage for the Company. The agreement will be the first opportunity to conduct commercial work in the space sector using Scanway’s competencies developed in the Industry area.

The product of the Agreement, a lunar image processing system, will be the first commercial project of its kind in Europe. The Company – in partnership with IM – will provide an optical instrument for mapping the lunar surface and – based on the Agreement – a data processing system. According to the Company, this combination represents a unique solution on a European scale and is an example of Scanway’s entry into the downstream segment – the most profitable segment of the space sector.

Due to the expansion of the Company’s cooperation with IM and ESA, the Agreement may provide a basis for further development and strengthening of cooperation between the entities.

The news that the key terms of cooperation mentioned above have been agreed with ESA was considered important for the Company, as this will be the first order for processing lunar images from Scanway’s optical instruments. This will allow the Company to acquire further key elements of the optical processing chain, which includes: acquisition, processing, data analysis and event prediction based on the data, which may have a positive impact on Scanway’s further development prospects and financial position in the coming years. The Company’s Board of Directors will announce the signing of the Agreement for the aforementioned contract in a separate current report.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current Report No. ESPI 9/2025
Drafting date: 2025-06-03
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Convening of the Annual General Meeting of Scanway S.A. for June 30, 2025.

Other regulations

The Board of Directors of Scanway Spółka Akcyjna with its registered seat in Wrocław, “the Company” or “the Issuer” announces that the Ordinary General Meeting of Shareholders of the Issuer has been convened for June 30, 2025, which will commence at 10:00 a.m. at Ruska 3/4 Street, 50-079 Wrocław, KBSR Kamińscy i Partnerzy Notary.
The detailed agenda of the convened Ordinary General Meeting of Shareholders of the Company includes:

1. Opening of the Assembly,
2. Election of the Chairman of the Assembly,
3. To ascertain the correctness of the convening of the General Meeting and its ability to adopt resolutions,
4. Adoption of a resolution on the election of the Ballot-Counting Committee or waiving its election,
5. Adoption of the agenda,
6. Presentation of the Board of Directors’ report on the Company’s activities, the Company’s financial statements for fiscal year 2024 and the Board of Directors’ proposal for covering the loss for fiscal year 2024,
7. Presentation of the Supervisory Board’s report for 2024,
8. adoption of resolutions on:
   a. consideration and approval of the Management Board’s report on the Company’s activities for the 2024 fiscal year,
   b. consideration and approval of the Company’s financial statements for the 2024 fiscal year,
   c. coverage of the net loss for the 2024 fiscal year,
   d. granting the Company’s Management Board Members a discharge of their duties for the 2024 fiscal year,
   e. granting a discharge to the Members of the Company’s Supervisory Board for the performance of their duties in the 2024 fiscal year; f. amending the Company’s Articles of Association;
   g. preparing financial statements in accordance with International Accounting Standards (IAS) and International Financial Reporting Standards (IFRS);
   h. Preparation of consolidated financial statements in accordance with International Accounting Standards (IAS) and International Financial Reporting Standards (IFRS);
   i. Changes in the composition of the Supervisory Board;
   j. Amendments to the Regulations of the General Meeting.
9. closing of the Assembly.

The full text of the notice convening the Company’s Annual General Meeting of Shareholders and the contents of the draft resolutions to be adopted at the Issuer’s Annual General Meeting of Shareholders are included in the appendices to the report.

In addition, in accordance with Article 4023 § 1 of the Commercial Companies Code, the full text of the notice convening the Ordinary General Meeting of Shareholders, along with attachments, including forms for exercising voting rights by proxy, is posted at https://investors.scanway.pl/.
Detailed legal basis: Articles 402 § 1 and 402 § 2 of the Commercial Companies Code.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current Report No. ESPI 8/2025
Drafting date: 2025-06-03
Abbreviated name of the issuer: SCANWAY S.A.

Subject: order for the implementation of a Hydra-based vision inspection system in the food industry for EvraFish Ltd.

Article 17(1) MAR – confidential information.

The Board of Directors of Scanway S.A. (the “Company”) announces that on June 3, 2025, it signed an order (the “Order”) from a company operating in the food industry, EvraFish Sp. z o.o. (“EvraFish”). The subject of the Order is the implementation of a vision system for the inspection of manufactured fish cans in an automated processing line at a production facility in Brusy. This is another commercialization of the Hydra system after the order from FABIOS S.A. (RB 3/2025) and the first Order from EvraFish. The value of the Order is €102,500, and it is expected to be completed by the end of 2025. Other terms and conditions of the Order’s execution do not differ from the provisions characteristic of this type of cooperation.

The system will perform automatic quality control of each can in the production process and will be used to detect defects in the final product using Hydra’s proprietary technology, advanced imaging methods and high-performance data analysis. Among other things, Hydra uses proprietary software based on artificial intelligence (machine learning) algorithms for image processing.

The cooperation with EvraFish is part of the Company’s strategy to offer products to customers in various industries, including the food industry. The solutions included in the system for continuous production control are the same as the Hydra product being developed by Scanway, and the food branch is one of the business priorities for the Company.

EvraFish is a renowned manufacturer of canned fish preparations based in Brusy (Pomeranian Voivodeship), specializing in private label production for external customers, as well as developing its own “brands.” EvraFish is part of Polski Holding Rybny. Polski Holding Rybny Sp. z o.o. (“PHR”) includes modern fish processing plants Libru Sea and Evrafish, as well as popular brands such as: Fjord Fiskursson, offering a wide range of baked and smoked fish, and Evrafish, known for its portfolio of canned fish with recipes based on natural ingredients. PHR’s products are widely available in nationwide retail chains and the wholesale market, as well as in most EU countries and China, both in the company’s brands and under private labels (so-called private label). The company is committed to full quality control and the supply chain – from catching to processing to distribution.

Mikolaj Podgorski – Member of the Management Board
Radoslaw Charytoniuk – Member of the Management Board

Current Report No. ESPI 6/2025
Drafting date: 2025-05-26
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Notifications of transactions of an obligated person and a closely related person received pursuant to Article 19 MAR.

Article 19 (3) MAR – information on transactions performed by persons discharging managerial responsibilities.

The Board of Directors of Scanway S.A. (the “Company”, “Scanway”) announces that today the Company has received a total of two notification notifications prepared in accordance with Article 19 of MAR from a person performing managerial duties (Scanway’s CEO) and a person closely related to him (a family foundation) regarding the transfer of 176,870 Company shares by the Company’s CEO to his related family foundation.

The content of the notifications received is provided by the Company in the appendix to this current report.

Jędrzej Kowalewski – President of the Management Board
Mikołaj Podgórski – Member of the Management Board

Current report no. ESPI 5/2025
Drafting date: 2025-05-26
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Receipt of a Purchase Order for the implementation of a vision control system for the food industry for Bunge Poland Ltd.

MAR Article 17.1 – confidential information.

The Management Board of Scanway S.A. (the “Company”) announces that on May 26, 2025, it signed an order (the “Order”) from Bunge Polska Sp. z o.o., a company operating in the food industry. (“Bunge”). The subject of the Order is the implementation of a vision system for the inspection of manufactured bottles of rapeseed oil on an automatic processing line at Bunge’s production plant in Kruszwica. The implemented solution is based on elements used in the Hydra system developed by the Company.

The system will allow inspection of each bottle including the cork and detection of defects in the final product using advanced imaging technologies and high-performance data analysis. In addition – as part of the signed Order – the Company will integrate the quality control system with an automatic rejecter of defective bottles, which will allow the immediate disposal of defective products from the production line.

The Order received by the Company consists of two elements:
– Element No. 1 for the implementation of the first stage of the control system, the implementation time of which is scheduled for the third quarter of this year. The value of this element of the Order is €64700;
– Element No. 2 for the implementation of the defective bottle rejection system, the implementation time of which is scheduled for the third quarter of this year. The value of this element of the Procurement will be settled on the basis of a labor hour rate and has been provisionally estimated at €10,000.

Completion of the aforementioned two elements under the Order received is scheduled for the third quarter of 2025. The other terms and conditions of the Order do not differ from the provisions characteristic of this type of cooperation.

The cooperation with Bunge is part of the Company’s strategy to offer products to customers in various industries, including the food industry. The offered system is part of the Company’s well-known area of high-performance final product control and is based on components used in the Hydra system. The food industry, in turn, is one of the Company’s business priorities.

Bunge Polska Sp. z o.o. is part of the multinational Bunge Global S.A., one of the largest companies operating globally in the agricultural and food sectors. Bunge is mainly engaged in the production of vegetable oils, vegetable fats, feeds and grain trade. The multinational Bunge operates in more than 40 countries and employs tens of thousands of people worldwide. In Poland, Bunge has several production plants, the largest of which is the aforementioned Production Plant in Kruszwica, Kujawsko-Pomorskie Province.

Mikolaj Podgorski – Member of the Management Board
Radoslaw Charytoniuk – Member of the Management Board

Current Report No. ESPI 16/2024
Drafting date: 2024-10-09
Abbreviated name of the issuer: SCANWAY S.A.

Subject: Notifications of transactions of an obligated person and a closely related person received pursuant to Article 19 MAR.

The Board of Directors of Scanway S.A. (the “Company”, “Scanway”) announces that the Company has received notification notices prepared in accordance with Article 19 MAR from the Chairman of the Board of Directors of Scanway and a person closely related to him (a family foundation) regarding the transfer by way of donation to the family foundation of 100.00 shares in the Company.

In addition, the Company announces that it has received a notification notice from the aforementioned closely related person (family foundation) regarding the sale of 100,000 Scanway shares under ABB’s accelerated book building process, which the Company announced in ESPI Current Report No. 15/2024.

The content of the notifications received is provided by the Company in the appendix to this current report.

Jędrzej Kowalewski – President of the Management Board
Michał Zięba – Member of the Management Board